Advanced Search
ZHAO Tianzeng, YANG Jinhua, LIU Xiangqian, XU Mengbo. miR-145 Attenuates Migration and Invasion of Non-small Cell Lung Cancer A549 Cells by Targeting AP4[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 110-114. DOI: 10.3971/j.issn.1000-8578.2019.18.1160
Citation: ZHAO Tianzeng, YANG Jinhua, LIU Xiangqian, XU Mengbo. miR-145 Attenuates Migration and Invasion of Non-small Cell Lung Cancer A549 Cells by Targeting AP4[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 110-114. DOI: 10.3971/j.issn.1000-8578.2019.18.1160

miR-145 Attenuates Migration and Invasion of Non-small Cell Lung Cancer A549 Cells by Targeting AP4

More Information
  • Received Date: August 04, 2018
  • Revised Date: September 09, 2018
  • Available Online: January 12, 2024
  • Objective 

    To investigate the effect of miR-145 on the migration and invasion of non-small cell lung cancer (NSCLC) cells and possible mechanism.

    Methods 

    The expression of miR-145 and activating enhancer binding protein 4 (AP4) mRNA in NSCLC tissues were detected by qRT-PCR. After the transfection with miR-145 mimic or AP4 siRNA, the migration and invasion of A549 cells were examined by wound healing and Transwell assay, respectively; The mRNA and protein expressions of AP4 were detected by qRT-PCR and Western blot, respectively. The relationship between AP4 mRNA and miR-145 was detected by double luciferase reporter gene method.

    Results 

    Compared with adjacent normal tissues, the level of miR-145 was significantly decreased in NSCLC tissues (P < 0.05), however, the mRNA and protein levels of AP4 were significantly increased (P < 0.05). Compared with control group, the level of miR-145 was significantly increased (P < 0.05), the mRNA and protein levels of AP4 were significantly decreased (P < 0.05), and cells migration and invasion were significantly decreased (P < 0.05) in A549 cells after the transfection with miR-145 mimic. Moreover, AP4 was a direct target of miR-145. After the transfection with AP4 siRNA, the migration and invasion of A549 cells were significantly decreased (P < 0.05).

    Conclusion 

    miR-145 upregulation could efficiently attenuate the migration and invasion of A549 cells via inhibiting target gene AP4 expression.

  • [1]
    Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide:sources, methods and major patterns in GLOBOCAN 2012[J].Int J Cancer, 2015, 136(5):E359-86. doi: 10.1002/ijc.29210
    [2]
    Balça-Silva J, Sousa Neves S, Gonçalves AC, et al.Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines[J].Anticancer Res, 2012, 32(5):1603-9. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=9e553c61fbb76e70300e33fa0770d47b
    [3]
    Ostenfeld MS, Bramsen JB, Lamy P, et al.miR-145 induces caspase-dependent and independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Tabladder tumors[J].Oncologene, 2010, 29(7):1073-84. http://onlinelibrary.wiley.com/resolve/reference/PMED?id=19915607
    [4]
    孙嘉伟, 刘凤霞, 刘文雅, 等.MicroRNA-145对食管鳞状细胞癌细胞增殖的影响[J].新疆医科大学学报, 2013, 36(6):756-8, 762. http://d.old.wanfangdata.com.cn/Periodical/xjykdxxb201306009

    Sun JW, Liu FX, Liu WY, et al.The effect of microRNA-145 on proliferation of esophageal squamous carcinoma cells[J].Xinjiang Yi Ke Da Xue Xue Bao, 2013, 36(6):756-8, 762. http://d.old.wanfangdata.com.cn/Periodical/xjykdxxb201306009
    [5]
    Ding W, Tan H, Zhao C,  et al.MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma[J].Tumour Biol, 2016, 37(5):6255-60.  doi: 10.1007/s13277-015-4462-3
    [6]
    Gao P, Xing AY, Zhou GY, et al.The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer[J].Oncogene, 2013, 32(4):491-501. doi: 10.1038/onc.2012.61
    [7]
    Sachdeva M, Mo YY.MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1[J].Cancer Res, 2010, 70(1):378-87. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=bfdcdb00c6ee02b3195275e1c346be0f
    [8]
    王寰昱, 王亚峰, 张昆松, 等.上调miRNA-145对肝癌细胞的作用及其机制研究[J].中国病理生理杂志, 2015, 31(6):1019-25. http://www.cnki.com.cn/Article/CJFDTotal-ZBLS201506011.htm

    Wang HY, Wang YF, Zhang KS, et al.Role of up-regulated microRNA145 in viability, apoptosis, invasion and metastasis of hepatoma cells[J].Zhongguo Bing Li Sheng Li Za Zhi, 2015, 31(6):1019-25. http://www.cnki.com.cn/Article/CJFDTotal-ZBLS201506011.htm
    [9]
    孙政, 曹杰, 杨平, 等.转录因子激活蛋白-4在结直肠癌中的表达及与细胞凋亡的相关性[J].中华实验外科杂志, 2008, 25(7):891-3. doi: 10.3321/j.issn:1001-9030.2008.07.028

    Sun Z, Cao J, Yang P, et al.Expression of activator protein-4 in colorectal carcinoma and its relationship with apoptosis[J].Zhonghua Shi Yan Wai Ke Za Zhi, 2008, 25(7):891-3. doi: 10.3321/j.issn:1001-9030.2008.07.028
    [10]
    Jung P, Hermeking H.The c-MYC-AP4-p21 cascade[J].Cell Cycle, 2009, 8(7):982-9. doi: 10.4161/cc.8.7.7949
    [11]
    Hu X, Guo W, Chen S, et al.Silencing of AP-4 inhibits proliferation, induces cell cycle arrest and promotes apoptosis in human lung cancer cells[J].Oncol Lett, 2016, 11(6):3735-42. doi: 10.3892/ol.2016.4451
    [12]
    Xinghua L, Bo Z, Yan G, et al.The overexpression of AP-4 as a prognostic indicator for gastric carcinoma[J].Med Oncol, 2012, 29(2):871-7. doi: 10.1007/s12032-011-9845-8
    [13]
    Hu BS, Zhao G, Yu HF, et al.High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy[J].Tumour Biol, 2013, 34(1):271-6. doi: 10.1007/s13277-012-0547-4
    [14]
    王小康, 解绪红, 陈文全, 等.转录因子激活蛋白4、血管内皮生长因子C在甲状腺乳头癌中的表达及意义[J].中华普通外科学文献(电子版), 2013, 7(1):36-9. http://d.old.wanfangdata.com.cn/Periodical/zhptwkxwx201301009

    Wang XK, Xie XH, Chen WQ, et al.Expression and clinical values of AP-4 and VEGF-C in papillary carcinoma of thyroid[J].Zhonghua Pu Tong Wai Ke Xue Wen Xian (Dian Zi Ban), 2013, 7(1):36-9. http://d.old.wanfangdata.com.cn/Periodical/zhptwkxwx201301009
    [15]
    别延红, 李纳, 吴又明, 等.转录因子增强结合蛋白-4基因沉默对子宫内膜癌细胞凋亡的影响[J].山东医药, 2017, 57(2):5-9. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shandyy201702002

    Bie YH, Li N, Wu YM, et al.Effects of silencing transcription factor AP-4 gene on apoptosis of endometrial cancer cells[J].Shandong Yi Yao, 2017, 57(2):5-9. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=shandyy201702002
    [16]
    Chen S, Chiu SK.AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells[J].Mol Cell Biochem, 2015, 407(1-2):57-68. doi: 10.1007/s11010-015-2454-7
    [17]
    Jackstadt R, Röh S, Neumann J,  et al.AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer[J].J Exp Med, 2013, 210(7):1331-50.  doi: 10.1084/jem.20120812
  • Related Articles

    [1]TIAN Tian, TANG Sudan. Association Between Platelet Lymphocyte Ratio and Prognosis of Non-small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Inhibitor: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 611-616. DOI: 10.3971/j.issn.1000-8578.2021.20.1052
    [2]WEI Xueling, LAN Mei, PENG Xinhao, ZHANG Hanyi, LONG En, LIU Hui, LANG Jinyi. Correlation Between Immune Function Status and EBV DNA in Patients with Nasopharyngeal Carcinoma and Their Influence on Prognosis[J]. Cancer Research on Prevention and Treatment, 2021, 48(6): 600-606. DOI: 10.3971/j.issn.1000-8578.2021.20.1402
    [3]Yeerhanati·Hudusi, Aerhengbieke·Tuhanbai, Aikebaier·Younusi. Relation Between NLR, LMR, PLR and Prognosis of Osteosarcoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(4): 381-386. DOI: 10.3971/j.issn.1000-8578.2021.20.0895
    [4]XU Liang, ZHANG Baihong. Prognostic Value of Lymphocyte-associated Inflammatory Markers in Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2020, 47(12): 936-941. DOI: 10.3971/j.issn.1000-8578.2020.20.1179
    [5]YAO Zhiqiang, ZHANG Xiangxiang, CHEN Chaohu, CAO Jinlong, HAN Dali, LI Pan, DONG Zhichun, TIAN Junqiang. Prognostive Value of Preoperative Fibrinogen Combined with Platelet-lymphocyte Ratio on Prognosis of Patients Undergoing Radical Cystectomy[J]. Cancer Research on Prevention and Treatment, 2020, 47(11): 834-838. DOI: 10.3971/j.issn.1000-8578.2020.19.1631
    [6]FU Yali, MEI Shiwen, WEI Xing, LUO Chenghua, LIN Li, LIANG Jun. Neutrophil to Lymphocyte Ratio in Retroperitoneal Liposarcoma and Other Prognostic Factors[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 127-130. DOI: 10.3971/j.issn.1000-8578.2019.18.1096
    [7]TANG Hong, WU Weili, JIN Feng, LONG Jinhua, LI Yuanyuan, LUO Xiuling, GONG Xiuyun, CHEN Xiaoxiao, ZHANG Mang, YANG Chunli. Relationship of Peripheral Blood Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio with Curative Effect and Prognosis of Patients with Locally Advanced Nasopharyngeal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2019, 46(1): 32-36. DOI: 10.3971/j.issn.1000-8578.2019.18.0578
    [8]ZHANG Tingting, WANG Xiangyi, GUO Ziwei, DING Xiaosheng, LIANG Jun. Prognostic Significance of Platelet-lymphocyte Ratio in Hepatocellular Carcinoma Patients: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2018, 45(10): 775-780. DOI: 10.3971/j.issn.1000-8578.2018.18.0151
    [9]HU Gen, LI Wei, SHAO Guoyi, ZHANG Xian. Predictive Effect of Preoperative Platelet-lymphocyte Ratio on Prognosis of Patients with Gastric Stromal Tumor[J]. Cancer Research on Prevention and Treatment, 2018, 45(7): 479-482. DOI: 10.3971/j.issn.1000-8578.2018.17.1428
    [10]ZHANG Sisi, YUAN Lei. Preoperative Platelet-to-lymphocyte Ratio and Neutrophil-to-lymphocyte Ratio for Predicting Prognosis of Esophageal Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(12): 811-815. DOI: 10.3971/j.issn.1000-8578.2017.17.0547

Catalog

    Article views PDF downloads Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return